Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study

被引：0
作者：
Thiemo J. A. van Nijnatten
B. Goorts
S. Vöö
M. de Boer
L. F. S. Kooreman
E. M. Heuts
J. E. Wildberger
F. M. Mottaghy
M. B. I. Lobbes
M. L. Smidt
机构：
[1] Maastricht University Medical Center+,Department of Radiology and Nuclear Medicine
[2] Maastricht University Medical Center+,Department of Surgery
[3] Maastricht University Medical Center+,GROW – School for Oncology and Developmental Biology
[4] Maastricht University Medical Center+,Division of Internal Medicine, Department of Medical Oncology
[5] Maastricht University Medical Center+,Department of Pathology
[6] RWTH Aachen University,Department of Nuclear Medicine, University Hospital
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2018年 / 45卷
关键词：
Breast cancer; Lymph node imaging; Hybrid PET/MRI; Axilla;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：179 / 186
页数：7
相关论文
共 160 条
  • [1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
  • [2] Bray F(2015)Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 26 v8-30
  • [3] Siegel RL(2012)Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer Ann Surg Oncol 19 1508-1516
  • [4] Ferlay J(2013)Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value? Breast 22 1108-1113
  • [5] Lortet-Tieulent J(2016)Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients Eur J Radiol 85 2288-2294
  • [6] Jemal A(2015)The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review Insights Imaging 6 203-215
  • [7] Senkus E(2012)Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy Breast Cancer Res Treat 135 231-240
  • [8] Kyriakides S(2014)Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations Radiology 273 859-869
  • [9] Ohno S(2010)Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer? Radiology 257 335-341
  • [10] Penault-Llorca F(2015)FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 Eur J Nucl Med Mol Imaging 42 328-354
12345678910